DBCO-PEG-OH (MW 400)
DBCO-PEG-OH (MW 400) is a PEG derivative composed of DBCO, PEG, and hydroxyl groups. DBCO-PEG-OH (MW 400) contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups[1].
Product Specifications
UNSPSC
12352200
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Others
Smiles
O=C(CCCCC(NCCO[H])=O)N(C1)C2=C(C=CC=C2)C#CC3=C1C=CC=C3.[n]
Molecular Weight
400 (Average)
References & Citations
[1]Koo J, et al. Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles. J Control Release. 2025 Feb 10;378:997-1012.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742078-500 1x 500 µL
TCL1 (T-Cell Marker) (TCL1/2078), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC043106-100 1x 100 µL
TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3106), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY433954 100 µg
LOC100505841 (NM_001195535) Human Over-expression Lysate
Sign In for Pricing
View Details 